Skip to main content

Table 1 The baseline characteristics of patients with ACLF

From: Nomogram based on blood lipoprotein for estimation of mortality in patients with hepatitis B virus-related acute-on-chronic liver failure

 Development group (n = 260)Validation group(n = 133)p
Age (year)45 ± 1245 ± 130.571
Gender (male/female)222/38108/250.310
Red blood cell count (× 1012/L)3.93 ± 0.913.88 ± 0.950.620
White blood cell count (×109/L)8.08 ± 3.569.43 ± 7.780.058
Hemoglobin (g/dL)119.92 ± 23.35118.58 ± 22.860.587
Albumin (g/L)31.76 ± 4.5431.42 ± 4.320.469
Alanine aminotransferase (U/L)707.38 ± 877.45649.70 ± 855.850.534
Prothrombin activity (%)29.28 ± 7.5727.87 ± 7.840.085
INR2.75 ± 1.003.05 ± 1.270.019
Creatinine (μmol/L)78.27 ± 44.7785.84 ± 70.730.262
Total bilirubin (μmol/L)378.86 ± 168.36376.05 ± 158.080.871
TC (mmol/L)2.44 ± 1.312.42 ± 1.050.849
TG (mmol/L)0.86 ± 0.520.96 ± 0.510.056
HDLC (mmol/L)0.19 ± 0.180.18 ± 0.170.546
LDLC (mmol/L)1.10 ± 0.601.06 ± 0.650.568
MELD scores, median (IQR)25.98 (23.13, 29.4)26.46 (24.16, 31.19)0.055
Ascites (yes/no)167/9395/380.175
mortality (yes/no)77/18337/960.726
  1. Abbreviations: INR international normalized ratio, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol